Publications

Ashfaq K, Yahaya I, Hyde C, Andronis L, Barton P, Bayliss S et al. Clinical effectiveness and cost-effectiveness of stem cell transplantation in the management of acute leukaemia: a systematic review. Health Technology Assessment 2010;14(54).

Pennant M, Takwoingi Y, Pennant L, Davenport C, Fry-Smith A, et al. A systematic review of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence. Health Technology Assessment 2010;14(50).

M Connock, S Tubeuf, K Malottki, A Uthman, J Round, S Bayliss, C Meads and D Moore. Certolizumab pegol (CIMZIA®) for the treatment of rheumatoid arthritis; Health Technology Assessment 2010; Vol. 14: Suppl. 2

J Dretzke, P Barton, B Kaambwa, M Connock, O Uthman, S Bayliss and C Meads. Rituximab for the treatment of relapsed/refractory chronic lymphocytic leukaemia; Health Technology Assessment 2010; Vol. 14: Suppl. 2

J Dretzke, J Round, M Connock, S Tubeuf, M Pennant, A Fry-Smith, C Hulme, C McCabe and C Meads. Imatinib as adjuvant treatment following resection of KIT-positive gastrointestinal stromal tumours; Health Technology Assessment 2010; Vol. 14: Suppl. 2

C Meads, J Round, S Tubeuf, D Moore, M Pennant and S Bayliss. Cetuximab for the first-line treatment of metastatic colorectal cancer; Health Technology Assessment 2010; Vol 14: Suppl. 1

S Bryan, L Andronis, C Hyde, M Connock, A Fry-Smith and D Wang. Infliximab for the treatment of acute exacerbations of ulcerative colitis; Health Technology Assessment 2010; Vol 14: Suppl. 1

M Connock, J Round, S Bayliss, S Tubeuf, W Greenheld and D Moore. Sorafenib for the treatment of advanced hepatocellular carcinoma; Health Technology Assessment 2010; Vol 14: Suppl. 1

R Edlin, M Connock, S Tubeuf, J Round, A Fry-Smith, C Hyde and W Greenheld. Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia; Health Technology Assessment 2010; Vol 14: Suppl. 1

Kelly SM, Wrightson PA, Meads CA. Clinical outcomes of exercise in the management of sub-acromial impingement syndrome: a systematic review.  Clinical Rehabilitation 2010;24(2):99-109

C Hyde, S Bryan, A Juarez-Garcia, L Andronis and A Fry-Smith. Infliximab for the treatment of ulcerative colitis; Health Technology Assessment 2009; Vol 13; Suppl. 3

Andronis L, Barton P, Bryan S. Sensitivity analysis in economic evaluation: an audit of NICE current practice and a review of its use and value in decision-making. Health Technology Assessment 2009;13(29).

Chen Y-F, Jowett S, Barton P, Malottki K, Hyde C, Gibbs JSR, Pepke-Zaba J, Fry-Smith A, Roberts J, Moore D. Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation. Health Technology Assessment 2009;13(49)

Meads C, Pennant M, McManus J, Bayliss S. A systematic review of lesbian, gay, bisexual and transgender health in the West Midlands region of the UK compared to published UK research. Report No. 71, 2009, Unit of Public Health, Epidemiology and Biostatistics, University of Birmingham. ISBN: 0704427222 - 9780704427228

Kongnyuy EJ, Uthman OA. Use of criterion-based clinical audit to improve the quality of obstetric care: a systematic review.. Acta Obstetricia et Gynecologica 2009;1-9 (first article)

Uthman OA. Patterns, distribution, and determinants of under- and overnutrition among women in Nigeria: a population-based analysis. Journal of Public Health e-published online 20 February 2009

Uthman OA. Using extended concentration and achievement indices to study socioeconomic inequality in chronic childhood malnutrition: the case of Nigeria. International Journal for Equity in Health 2009;8:22

Aveyard P, Wang D, Connock M, Fry-Smith A, Barton P, Moore D. Assessing the outcomes of prolonged cessation-induction and aid-to-cessation trials: Floating prolonged abstinence. Nicotine and Tobacco Research 2009;11(5):475-480

Dretzke J, Davenport C, Frew E, Barlow J, Stewart-Brown S, Bayliss S, Taylor RS, Sandercock J, Hyde C. The clinical effectiveness of different parenting programmes for children with conduct problems: a systematic review of randomised controlled trials. Child and Adolescent Psychiatry and Mental Health 2009;3:7

Moore D, Aveyard P, Connock M, Wang D, Fry-Smith A, Barton P. Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis. BMJ 2009; 338:b1024

Kidney E, Winter HR, Khan KS, Gulmezoglu AM, Meads CA, Deeks JJ, Macarthur C. Systematic review of effect of community-level interventions to reduce maternal mortality. BMC Pregnancy and Childbirth 2009;9:2

Meads C, Davenport CF. Quality assessment of diagnostic before-after studies: development of methodology in the context of a systematic review. BMC Medical Research Methodology 2009;9:3

Uthman O, Chen Y-F, Fry-Smith A, Moore D. Clinical and cost-effectiveness of self-monitoring of blood glucose (SMBG) for non-insulin treated type 2 diabetes. January 2009.Quality Improvement Scotland. Evidence Note 26

Kahveci R, Meads C. Is primary care evidence-based in Turkey? A cross-sectional survey of 375 primary care physicians. Journal of Evidence Based Medicine 2009;2:242-51

Moore D, Adi Y, Connock M, Bayliss S. Clinical effectiveness and cost-effectiveness of pegvisomant for the treatment of acromegaly: a systematic review and economic evaluation. BMC Endocrine Disorders 2009, 9:20

Cnossen JS, ter Riet G, Mol BW, van der Post JA, Leeflang MM, Meads C, Hyde C, Khan KS. Are tests for predicting pre-eclampsia good enough to make screening viable? A review of reviews and critical appraisal. Acta Obstetricia et Gynecologica Scandinavica 2009;88(7):758-765

Kidney E, Winter HR, Khan KS, Gulmezoglu AM, Meads CA, Deeks JJ, Macarthur C. Systematic review of effect of community-level interventions to reduce maternal mortality. BMC Pregnancy and Childbirth 2009;9:2

Pennant ME, Bayliss SE, Meads CA. Improving lesbian, gay and bisexual healthcare: a systematic review of qualitative literature from the UK. Diversity in Health and Care 2009;6(3):193-204

Albon E, Tsourapas A, Frew E, Davenport C, Oyebode F, Bayliss S, Arvanitis T, Meads CA. Structural neuroimaging in psychosis. Systematic review and economic evaluation. Health Technology Assessment 2008;12(18)

Chen Y-F, Jobanputra P, Barton P, Bryan S, Fry-Smith A, Harris G, Taylor RS. Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation. Health Technology Assessment 2008;12(11)

Meads CA, Cnossen JS, Meher S, Juarez-Garcia A, ter Riet G, Duley L, Roberts T, Mol BW, van der Post J. Leeflang MM, Barton PM, Hyde CJ, Gupta JK, Khan KS. Methods of prediction and prevention of pre-eclampsia – systematic reviews of accuracy and effectiveness literature with economic modelling. Health Technology Assessment 2008;12(6)

Wang D, Cummins C, Bayliss S, Sandercock J, Burls A. Immunoprophylaxis against respiratory syncytial virus (RSV) with palivizumab in children: a systematic review and economic evaluation. Health Technology Assessment 2008;12(36)

Wang D, Connock M, Barton P, Fry-Smith A, Aveyard P and Moore D. 'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis. Health Technology Assessment 2008;12: 2 February 2008

Williams I, McIver S, Moore D, Bryan S. The use of economic evaluations in NHS decision-making: a review and empirical investigation. Health Technology Assessment 2008;12(7)

Bayliss S, Davenport C. Locating systematic reviews of test accuracy studies: how five specialist reviews databases measure up. International Journal of Technology Assessment in Health Care 2008;24(4):403-411

Chen Y-F, Fry-Smith A, Moore D. Quality Improvement Scotland. Evidence Note 22: The clinical and cost effectiveness of surgical insertion of grommets for otitis media with effusion (glue ear) in children. January 2008. Available at: http://www.nhshealthquality.org/nhsqis/files/EN22%20Grommets.pdf

Cnossen JS, van der Post JA, Mol BW, Khan KS, Meads CA, ter Riet G. Prediction of pre-eclampsia: a protocol for systematic reviews of test accuracy. In Cnossen JS. Prediction of pre-eclampsia, systematic reviews of test accuracy literature. University of Amsterdam, Amsterdam 2008 (book chapter)

Glanville J, Bayliss S, Booth A, Dundar Y, Fernandes F, Fleeman ND et al. So many filters, so little time: the development of a search filter appraisal checklist. Journal of the Medical Library Association 2008;96(4):356-361

Kahveci R, Meads C. Analysis of the strengths and weaknesses, opportunities and threats in the development of a health technology assessment program in Turkey. International Journal of Technology Assessment in Healthcare 2008;24(2):235-40

Moore D, Connock MJ, Wraith E, Lavery C. The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK. Orphanet J Rare Dis. 2008 16;3(1):24.

Rodriguez-Cobo I, Chen Y-F, Olowokure B, Litchfield I. Clinical and economic assessment of different general population strategies of pertussis vaccine booster regarding number of doses and age of application for reducing whooping cough disease burden: a systematic review. Vaccine 2008;26(52):6768-6776

Uthman O, Chen Y-F, Fry-Smith A, Moore D. Acupuncture for low back pain. Quality Improvement Scotland. Evidence Note 24 2008.

Albon E, Tsourapas A, Frew E, Davenport C, Oyebode F, Bayliss S, Arvanitis T, Meads CA. Structural neuroimaging in psychosis. Systematic review and economic evaluation. Health Technology Assessment 2008;12(18)

Chen Y-F, Jobanputra P, Barton P, Bryan S, Fry-Smith A, Harris G, Taylor RS. Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and econimic evaluation. Health Technology Assessment 2008;12(11)

Meads CA, Cnossen JS, Meher S, Juarez-Garcia A, ter Riet G, Duley L, Roberts T, Mol BW, van der Post J. Leeflang MM, Barton PM, Hyde CJ, Gupta JK, Khan KS. Methods of prediction and prevention of pre-eclampsia – systematic reviews of accuracy and effectiveness literature with economic modelling. Health Technology Assessment 2008;12(6)

Wang D, Connock M, Barton P, Fry-Smith A, Aveyard P, Moore D. ‘Cut Down to Quit’ with Nicotine Replacement Therapies in Smoking Cessation: A Systematic Review of the Effectiveness and Economic Analysis. Health Technology Assessment 2008;12(2)

Williams I, McIver S, Moore D, Bryan S. The use of economic evaluations in NHS decision-making: a review and empirical investigation. Health Technology Assessment 2008;12(7)

Wilson J, Fry-Smith A, Goodwin J, Hawker J, Taylor R. A systematic review of the biological and health effects of exposure to cold temperature in healthy and diseased adults including the elderly. Department of Health.

Connock M, Stevens C, Fry-Smith A, Jowett S, Fitzmaurice D, Moore D and Song F Clinical effectiveness and cost-effectiveness of different models of managing long-term oral anticoagulation therapy: a systematic review and economic modelling. Health Technology Assessment 2007; 11 (38) October 2007

Wilson J, Yao GL, Raftery J, Bohlius J, Brunskill S, Sandercock J, Bayliss S, Moss P, Stanworth S, Hyde C. A systematic review and economic evaluation of epoetin alfa, epoetin beta and darbepoetin alfa in anaemia associated with cancer, especially that attributable to cancer treatment. Health Technology Assessment 2007;11(13)

Connock M, Juarez-Garcia A, Jowett S, Frew E, Liu Z, Taylor RJ, Fry-Smith A, Day E, Lintzeris N, Roberts T, Burls A, Taylor RS. Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. Health Technology Assessment 2007 11(9)

Adi Y, Juarez-Garcia A, Wang D, Jowett S, Frew E, Day E, Bayliss S, Roberts T, Burls A. Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: a systematic review and economic evaluation. Health Technology Assessment 2007;11(6)

Evans BW, Clark WK, Moore DJ, Whorwell PJ. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD003960. DOI: 10.1002/14651858.CD003960.pub3

Larder B, Wang D, Revell A et al. The development of artificial neural networks to predict virological response to combination HIV therapy. Antiviral Therapy 2007;12:15-24

Connock M, Frew E, Evans B-W, Bryan S, Cummins C, Fry-Smith A, Li Wan Po A, Sandercock J. The clinical effectiveness and cost-effectiveness of newer drugs for children with epilepsy. A systematic review. Health Technology Assessment 2006;10(7)

Yao G, Albon E, Adi Y, Milford D, Bayliss S, Ready A, Raftery J, Taylor RS. A systematic review and economic model of the clinical and cost-effectiveness of immunosuppressive therapy for renal transplantation in children. Health Technology Assessment 2006;10(49)

Chen Y-F, Jobanputra P, Barton P, Jowett S, Bryan S, Clark W, Fry-Smith A, Burls A. A systematic review of the effectiveness of adalimumab etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness. Health Technololgy Assessment 2006;10(42)

Connock M, Burls A, Frew E, Fry-Smith A, Juarez-Garcia A, McCabe C, A Wailoo, K Abrams, N Cooper, A Sutton, A O’Hagan, D Moore. The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher’s disease: a systematic review. Health Technololgy Assessment 2006;10(24)

Connock M, Juarez-Garcia A, Frew E, Mans A, Dretzke J, Fry-Smith A, Moore D. A systematic review of the clinical effectiveness and cost-effectiveness of enzyme replacement therapies for Fabry's disease and mucopolysaccharidosis type 1. Health Technololgy Assessment 2006;10(20)

Bayliss S, Dretzke J. Health technology assessments in social care: a case study of RCT retrieval. International Journal of Technology Assessment in Health Care Winter 2006;22(1)

Saunders P, Kibble A, Burls A. Investigating alleged clusters. In: Pencheon D, editor. Oxford Handbook of Public Health Practice. Oxford University Press; 2006. p. 130-138.

Glasziou P, Djulbegovic B, Burls A. Are systematic reviews more cost-effective than randomised trials? Lancet Vol 367 2006

Brice A, Burls A, Hill A. Finding and appraising evidence. In: Pencheon D, editor. Oxford Handbook of Public Health Practice. Oxford University Press; 2006. p. 184-192.

Burls A, Jordan R, Barton P, Olowokure B, Wake B, Albon E, Hawker J. Vaccinating healthcare workers against influenza to protect the vulnerable - Is it a good use of healthcare resources?

A systematic review of the evidence and an economic evaluation. Vaccine 24 (2006) 4212–4221 (pdf). Click here to view the model referred to in the report.

Dretzke J, Burls A, Bayliss S, Sandercock J. The clinical effectiveness of pre-hospital intravenous fluid replacement in trauma patients without head injury: a systematic review. Trauma 2006;8(3):131-141

Roberts JR. A mapping exercise of the systematic review evidence of effectiveness for acupuncture. Focus Alternative Complementary Therapy 2006;11:40

Price CJ, Wang D, Menon DK, Guadagno JV, Cleij M, Fryer T et al. Intrinsic activated microglia map to the peri-infarct zone in the subacute phase of ischemic stroke. Stroke 2006;37(7):1749-1753

Dretzke J, Frew E, Davenport C, Barlow J, Stewart-Brown S, Sandercock J, Bayliss S, Raftery J, Hyde C, Taylor R. The effectiveness and cost-effectiveness of parent training/education programmes for the treatment of conduct disorder, including oppositional defiant disorder, in children. Health Technology Assessment 2005;9(50)

Wilson J, Connock M, Song F, Yao G, Fry-Smith A, Raftery J, Peake D. Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours: systematic review and economic evaluation. Health Technology Assessment 2005;9(25)

Woodroffe R, Yao GL, Meads C, Bayliss S, Ready A, Raftery J, Taylor RS. Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study. Health Technology Assessment 2005;9(21)

Willis BH, Barton P, Pearmain P, Bryan S, Hyde C. Cervical screening programmes: can automation help? Evidence from systematic reviews, an economic analysis and a simulation modelling exercise applied to the UK. Health Technology Assessment 2005;9(13)

Burls A, Austin D, Moore D. Commissioning for rare diseases: view from the frontline. BMJ
2005;331:1019-1021.

Connock M, Jordan R, Fry-Smith A, Chen YF, Hawker J, Albon E and Burls A. Influenza vaccination of children and household contacts for the indirect protection of others: A systematic review of clinical and cost-effectiveness. Department of Public Health and Epidemiology, West Midlands Health Technology Assessment Group DPHE 2005, Report Number 53

Dawes M, Summerskill W, Glasziou P, Cartabellotta A, Burls A. Sicily statement on evidence-based practice. BMC Medical Education 2005 5:1

Bohlius J, Wilson J, Bayliss S, Djulbegovic B, Hyde C, Trelle S et al. Epoetin and darbepoetin to treat cancer patients: updated meta-analysis results. Blood 2005;106(11 Part 1):751

Song FJ, Fry-Smith A, Davenport C, Bayliss S, Adi Y, Wilson JS, Hyde C. Identification and assessment of ongoing trials in health technology assessment reviews. Health Technology Assessment 2004;8(44)

W Clark, P Jobanputra, P Barton, A Burls. The clinical and cost-effectiveness of Anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis. Health Technology Assessment 2004;8(18)

J Dretzke, J Sandercock, S Bayliss, Burls A. Clinical effectiveness and cost effectiveness of prehospital intravenous fluids in trauma patients. Health Technology Assessment 2004;8(23)

J Dretzke, Cummins C, J Sandercock, Fry-Smith A, Barrett T, Burls A. Auto antibody testing in children with newly diagnosed type 1 diabetes mellitus.Health Technology Assessment 2004;8(22)

Barton P, Jobanputra P, Wilson J, Bryan S, Burls A. The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis. Health Technology Assessment 2004;8(11)

W Clark, J Raftery, F Song, P Barton, C Cummins, A Fry-Smith, Burls A. Systematic review and economic evaluation of the effectiveness of Infliximab for the treatment of crohn’s disease. Health Technology Assessment 2003;7(3)

Meads C, Salas C, Roberts T, Moore D, Fry-Smith A, Hyde C. Clinical effectiveness and cost utility of photodynamic therapy for wet age-related macular degeneration: a systematic review and economic evaluation. Health Technology Assessment 2003;7(9)

Song FJ, Barton P, Sleightholme V, Yao GL, Fry-Smith A. Screening for fragile X syndrome: a literature review and modelling study. Health Technology Assessment 2003;7(16)

Burls A. Bradley P. Public Health Ethics. In: Medical Ethics Today – the practice and philosophy. London: BMA 2003

Pitches D, Burls A, Fry-Smith A. How to make a silk purse from a sow's ear - a comprehensive review of strategies to optimise data for corrupt manager and incompetent clinicians. BMJ 2003;327:1436-9

Burls A, Sandercock J. How to make a compelling submission to NICE: tips for sponsoring organisations. BMJ 2003;327:1446-8

Davenport C.F, Elley K, Fry-Smith A, Taylor-Weetman C, Taylor, RS. The Effectiveness of Routine Dental Checks: A Systematic Review of the Evidence Base. British Dental Journal 2003; 2:87-98

Adi Y, Ashcroft D, Browne K, Beech A, Fry-Smith A, Hyde C. Clinical effectiveness and cost-consequences of Selective serotonin reuptake inhibitors in the treatment of sex offenders. Health Technology Assessment 2002;6(28)

Burls A, Clark W, Stewart T, Preston C, Bryan S, Jefferson T, Fry-Smith A. Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation. Health Technology Assessment 2002;6(9).

Cummins C, Connock M, Fry-Smith A, Burls A. A systematic review of effectiveness and economic evaluation of new drug treatments for juvenile idiopathic arthritis: etanercept. Health Technology Assessment 2002;6(17)

Hyde C, Wake B, Bryan S, Barton P, Fry-Smith A, Davenport C, Song F. Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: a technology assessment. Health Technology Assessment 2002;6(2).

Jobanputra P, Barton P, Bryan S, Burls A. The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation. Health Technology Assessment 2002;6(21).

Wake B, Hyde C, Bryan S, Barton P, Song F, Fry-Smith A, Davenport C. Rituximab as third-line treatment for refractory or recurrent Stage III or IV follicular non-Hodgkins's lymphoma: a systematic review and economic evaluation. Health Technology Assessment 2002;6(3).

Woolacott NG, Jones L, Forbes CA, Mather LC, Sowden AJ, Song F, Raftery JP, Aveyard PN, Hyde CJ, Barton PM. The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation. Health Technology Assessment 2002;6(16)

Jones BW, Moore DJ, Robinson SM, Song F. A systematic review of tegaserod for the treatment of irritable bowel syndrome. Journal of Clinical Pharmacy and Therapeutics, 2002; 27:343-352 

Jobanputra P, Parry D, Fry-Smith A, Burls A. Effectiveness of autologous chondrocyte transplantation for hyaline cartilage defects in knees: a rapid systematic review. Health Technology Assessment 2001;5(11).

Lilford R, Richardson A, Stevens A, Fitzpatrick R et al. Issues in Methodological Research: Perspectives from Researchers and Commissioners. Health Technology Assessment 2001;5 1-57

Stewart A, Sandercock J, Bryan S, Hyde C, Barton PM, Fry-Smith A, Burls A. The clinical effectiveness and cost-effectiveness of riluzole for motor neurone disease: a rapid and systematic review. Health Technology Assessment 2001;5(2).

Burls A, Meara J. Investigating a disease cluster. Oxford Handbook of Public Health Ed. Pencheon D, Muir Gray JA, Guest C, Melzer D. Oxford University Press 2001 515-21

Meads C, Gold L, Burls A. How effective is outpatient care compared to in-patient care for the treatment of anorexia nervosa? A systematic review. European Eating Disorders Review. 2001; 9:229-241

Song F, Sheldon TA, Sutton A, Abrams K, Jones D. Methods for dealing with heterogeneity in meta-analysis. Evaluation and the Health Professions, 2001; 24 (2): 126-51

Sutton AJ, Jones DR, Abrams KR, Sheldon TA, Song F. Meta-analysis in health technology assessment. In: Stevens A, Abrams K, Brazier J, Fitzpatrick R, Lilford R. (ed) Advanced handbook of methods in evidence based healthcare. SAGE Publications 2001, London, Thousand Oaks, New Delhi

Marshall T, Simpson S, Stevens A. Use of health services by prison inmates: comparisons with the community. Journal of Epidemiology Community Health, 2001; 55 (5): 364-5

Ostler K, Thompson C, Kinmonth A-L, Peveler R, Stevens L, Stevens A. The influence of socio-economic deprivation on the prevalence and outcome of depression in primary care: The Hampshire depression project. Brit J Psych, 2001; 178 (1): 12-17

Sutcliffe N, Clarke AE, Taylor R, Frost C, Isenberg DA.Total costs and predictors of costs in patients with systemic lupus erythematosus. Rheumatology, 2001; 40 (1): 37-47

Branas P, Jordan R, Fry-Smith A, Burls A, Hyde C. Treatments for fatigue in multiple sclerosis: a rapid and systematic review. Health Technology Assessment 2000;4(27).

Meads C, Cummins C, Jolly K, Stevens A, Burls A, Hyde C. Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review. Health Technology Assessment 2000;4(23)

Song F, O'Meara S, Wilson P, Golder S, Kleijnen J. The effectiveness and cost-effectiveness of prophylactic removal of wisdom teeth. Health Technol Asses 2000;4(15).

Song F, Eastwood A, Gilbody S, Duley L, Sutton A. Publication and related biases. Health Technology Assessment 2000; 4(10): 1-115.

Jordan R, Cummins C, Burls A. Laser resurfacing of the skin for the improvement of facial acne scarring: a systematic review of the evidence.British Journal of Dermatology 2000; 142:413-423

Meads C, Bradley P, Burls A. The effectiveness of specific epilepsy services. Birmingham: Department of Public Health & Epidemiology, University of Birmingham. November 2000 ISBN: 07044 22735

Burls A, Cabello-Lopez J. Research methods in public health. In: Ethics in public health and community medicine. Eds. Bradley P, Burls A. 2000 London: Routledge

Burls A. Public participation and public health. In: Ethics in public health and community medicine. Eds. Bradley P, Burls A. London: Routledge, 2000

Burls A. Una visión global de la medicina basada en la evidencia en el Reino Unido [A global vision of evidence-based medicine in the United Kingdom]. In: Memoria del seminario internacional de medicina basada en la evidencia. Ed. Vallejo M. Mexico: Secretaría De Salud, 2000.

Cummins C, Hyde C, Meads C, Jolly K, Burls A. Rapid health technology assessment: what can be done in six weeks? Statistics in Medicine

Jordan R, Cummins C, Burls A. Laser resurfacing of the skin for the improvement of facial acne scarring: a systematic review of the evidence.British Journal of Dermatology 2000; 142:413-423

Roberts L, Gold L, Moore D, Elley K. The effectiveness of health assessments in primary care as a strategy for improving both physical and mental health in patients with schizophrenic illness. WMHTAC, Department of Public Health and Epidemiology, University of Birmingham , Birmingham, UK. Publication: 12443. ISBN:07044 23693

Song F, Glenny AM, Altman DG. Indirect comparison in evaluating relative efficacy: illustrated by antimicrobial prophylaxis in colorectal surgery. Controlled Clinical Trials 2000; 21:488-497.

Gilbody SM, Song F, Eastwood AJ, Sutton A. The causes, consequences and detection of publication bias in psychiatry. Acta Psychiatr Scand 2000; 101:1-9.

Gilbody SM, Song F. Publication bias and the integrity of psychiatry research. Psychological Medicine 2000; 30:253-258.

Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F. Methods for meta-analysis in medical research. John Wiley & Sons, Ltd. 2000.

Sutton AJ, Song F, Gilbody SM, Abrams KR. Modelling publication bias in meta-analysis: a review. Statistical Methods in Medical Research, 2000; 9 (5): 421-445

Kennedy E, Song F, Hunter R, Clark A, Gilbody S. Risperidone versus typical antipsychotic medication for schizophrenia. The Cochrane Library, issue 3, 2000.

Stevens A, Raftery J, Mant J. Health Care Needs Assessment (2 vols) 1st series, second edition. Radcliffe 2000 (in press)

Rouse A, Jolly K, Stevens A. Has Calman-Hine succeeded? Analysis of breast cancer procedure loads per consultant firm before and after the Calman-Hine report. The Breast (2000);9 (accepted)

Rouse A, Wilson R, Stevens A. If the NHS introduced a “50 procedures a year” policy what proportion of NHS consultants would be affected? Journal of Public Health Medicine, 2000; 23 (1): 65-8

Chase D, Milne R, Stein K, Stevens A. What are the relative merits of the sources used to identify potential research priorities for the NHS HTA programme? International Journal of Technology Assessment in Health Care. 2000; 16:3 743-750

Booth-Clibborn N, Packer C, Stevens A. Health technology diffusion rates: statins, coronary stents, and MRI in England. Int J Tech Asst in Health Care 2000; 16:3 781-786

Taylor RS, Reeves BJ, Ewings P, Mears R, Keast J. A systematic review of the effectiveness of critical appraisal skills training for healthcare professionals. Medical Education 2000;34:120-5

Taylor RS, Smith HJ, Mitchel A.A comparison of four quality of life instruments in cardiac patients: Short-from 36 (SF-36), Quality of Life Index-Cardiac Version (QLI), Quality of Life after Myocardial Infarction (QLMI), and Schedule for the Evaluation of Individual Quality of Life (SEIQoL). Heart 2000 (in press)

Jolliffe J, Taylor R, Rees K, Ebrahim S, Oldridge N, Thompson D.A systematic review of the exercise based cardiac rehabilitation for patients with cardiac disease. Cochrane Collaboration, ed. Cochrane Library. Oxford: Update Software, 2000. Cochrane Library of Systematic Reviews

Taylor RS. Pharmaceutical regulation: the early experience of the NHS National Institute for Clinical Excellence (NICE) appraisal process – where are we headed? Value in Health 2000 (in press)

Lewin RJ, Thompson DR, Taylor RS. Cardiac rehabilitation. European Heart Journal 2000;May 21(10):860-1

Awonuga AO, Dwarakanath LS, Khan KS, Taylor R. Postgraduate obstetrics and gynaecology trainee’s views and understanding of evidence-based medicine. Medical Teacher 2000;22:27-29

Glenny AM, Song F. Antimicrobial prophylaxis in total hip replacement: a systematic review. Health Technology Assessment 1999; 3(21): 1-57.

Robert G, Stevens A, Gabbay G. Early warning systems for identifying new health care technologies. Health Technology Assessment 1999; 3: 13

Burls A. Do half-day workshops aimed at teaching critical appraisal skills work? Oxford: Institute of Health Sciences. 1999. ISBN: 18407 50057

Hyde CJ, Fry-Smith A, Young J. Finding literature on pre-hospital emergency care. Pre-Hospital Immediate Care 1999; 3: 22-32

Cummins C, Hyde C, Meads C, Jolly K, Burls A. Rapid health technology assessment: what can be done in six weeks? Statistics in Medicine (In press)

Parmar MKB, Torri V, Colombo N, Williams CJ & Sandercock J.ICON2 trial. Lancet, 1999; 353: 588

Song F, Eastwood A, Gilbody S, Duley L. The role of electronic journals in reducing publication bias. Medical Informatics - an International Journal of Information Processing in Health Care 1999; 24(3):223-229

Petticrew M, Song F, Wilson P, Wright K, et al. Quality-assessed reviews of health care interventions and the database of abstracts of reviews of effectiveness (DARE). International Journal of Technology Assessment in Health Care 1999; 15 (4): 671-678.

Song F. Exploring heterogeneity in meta-analysis: is the L’Abbe plot useful? Journal of Clinical Epidemiology 1999; 52(8): 725-730.

Stevens A, Milne R, Lilford R, Gabbay G. Keeping pace with new technologies. BMJ 1999; 319: 1291

Edwards S, Braunholtz D, Lilford R, Stevens A. Ethical issues in the design and conduct of cluster randomised controlled trials. BMJ 1999; 318: 1407-1409

Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F. Systematic reviews of trials and other studies. Health Technology Assessment 1998; 2(19): 1- 272.

Song F, Glenny AM. Antimicrobial prophylaxis in colorectal surgery: a systematic review of randomized controlled trials. Health Technology Assessment 1998; 2(7):1-110.

Parmar MKB, Torri V, Bonaventura A, Bonazzi C, Colombo N, Delaloye J-F, Marsoni S, Mangioni C, Sandercock J & Williams C on behalf of the ICON Collaborators.ICON2: a randomised trial of single agent carboplatin against the 3-drug combination of CAP (cyclophosphamide, doxorubicin and cisplatin) in women with ovarian cancer. Lancet, 1998; 352: 1571-1576

Sandercock J, Parmar MKB & Torri V. First-line chemotherapy for advanced ovarian cancer: paclitaxel, cisplatin and the evidence. British Journal of Cancer, 1998; 78 (11): 1471-1478

Song F, Glenny A.M. Antimicrobial prophylaxis in colorectal surgery: a systematic review of randomized controlled trials. British Journal of Surgery 1998; 85: 1232-1241.

Song F, Sheldon T. Discrepancy of meta-analysis and large-scale trials (letter). New England Journal of Medicine 1998; 338:60.

Stevens A, Gillam S. Needs assessment from theory to practice. BMJ 1998;316:

Raftery J, Stevens A. Day case surgery trends in England: the influences of target setting and of general practitioner fundholding. Journal of Health Services Research & Policy 1998; 3:149-152

Stevens A, Milne R.A knowledge-based health service: how do the new initiatives work? Journal of the Royal Society of Medicine 1998; (Suppl. 35):26-31

Stevens A, Packer C, Robert G. Early warning of new health care technologies in the United Kingdom. International Journal of Technology Assessment in Health Care 998; 14: 680-686.

Taylor RS, Kirby BJ, Burdon D, Caves R. The assessment of recovery in post-myocardial infarction patients using three generic quality of life measures. Journal of Cardiopulmonary Rehabilitation 1998;18:139-44

Jolliffe J, Taylor RS. Physical activity and cardiac rehabilitation: a critical review of the literature. Coronary Health Care 1998;2:179-186

Taylor RS, Stockman J, Kernick D, Shore A, Tooke J. Ambulatory blood pressure monitoring for hypertension in general practice. Journal of the Royal Society of Medicine 1998;91:301-4